Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Al-Mufti R, Pedley RB, Marshall D, Begent RH, Hilson A, Winslet MC and Hobbs KEF (1999) In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines. Br J Cancer 79: 1665–1671
Ho S, Lau WY, Leung TWT and Johnson PJ (1998) Internal radiation therapy for patients with primary or metastatic hepatic cancer. A review. Cancer 83: 1894–1907
Lau WY, Leung TWT, Ho SKW, Chan M, Machin D, Lau J, Chan ATC, Yeo W, Mok TSK, Yu SCH, Leung N and Johnson PJ (1999) Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma – a prospective randomized trial. Lancet 353: 797–801
Leung WT, Lau WY, Ho S, Chan M, Leung N, Lin J, Ho KC, Metreweli C, Johnson PJ and Li AKC (1994) Selective internal radiation therapy with intraarterial 131Iodine-Lipiodol in inoperable hepatocellular carcinoma. J Nucl Med 35: 1313–1318
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines. Br J Cancer 82, 497–498 (2000). https://doi.org/10.1054/bjoc.1999.0950
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.0950
